Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
Appointed director
|
|
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/14/2022 |
3
| DIXON WENDY L (Director) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
| 03/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/17/2020 |
3
| Bellemin Jean-Marc (CFO) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
| 06/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/19/2019 |
3
| GRAF FINCKENSTEIN FRIEDRICH (Chief Medical Officer) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
| 06/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/19/2018 |
3
| WEISER MICHAEL (Director) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
| 10/20/2017 |
3
| Vogt Frederick G (General Counsel) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
| 08/16/2017 |
3
| MORRIS TIMOTHY E (CFO) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
| 04/03/2017 |
3
| Valle Franco (Principal Accounting Officer) has filed a Form 3 on Lion Biotechnologies, Inc. |
| 10/06/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/10/2016 |
3
| Dukes Iain D. (Director) has filed a Form 3 on Lion Biotechnologies, Inc. |
| 06/15/2016 |
3
| Rothbaum Wayne P. (Director) has filed a Form 3 on Lion Biotechnologies, Inc. |
| 06/09/2016 |
3
| Fardis Maria (President & CEO) has filed a Form 3 on Lion Biotechnologies, Inc. |
| 03/30/2016 |
3
| Lotze Michael (Chief Scientific Officer) has filed a Form 3 on Lion Biotechnologies, Inc. |
| 09/11/2013 |
3
| Hillsberg Sanford (Director) has filed a Form 3 on Genesis Biopharma, Inc |
| 08/01/2013 |
3
| Singh Manish (President & CEO) has filed a Form 3 on Genesis Biopharma, Inc |
| 06/11/2013 |
3
| KESSLER PAUL (Director) has filed a Form 3 on Genesis Biopharma, Inc |
| 05/31/2013 |
3
| Ayer Capital Management, LP (10% Owner) has filed a Form 3 on Genesis Biopharma, Inc |
| 06/11/2012 |
3
| BRISTOL INVESTMENT FUND LTD (10% Owner) has filed a Form 3 on Genesis Biopharma, Inc |
| 09/30/2011 |
3
| Schroeder Martin (Director) has filed a Form 3 on Genesis Biopharma, Inc |
| 09/26/2011 |
3
| MCPEAK MERRILL A/ (Director) has filed a Form 3 on Genesis Biopharma, Inc |
| 03/25/2011 |
3
| Cataldo Tony (CEO, President) has filed a Form 3 on Genesis Biopharma, Inc |
| 03/25/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/25/2011 |
3
| Coles L. Stephen (Director) has filed a Form 3 on Genesis Biopharma, Inc |
| 03/24/2011 |
3
| Andrews William H (Director) has filed a Form 3 on Genesis Biopharma, Inc |
| 11/04/2010 |
3
| Hamilton Atlantic (10% Owner) has filed a Form 3 on Genesis Biopharma, Inc |
| 04/08/2010 |
3
| Ahn Mark J (Director) has filed a Form 3 on Genesis Biopharma, Inc |
| 03/22/2010 |
3
| MCKILLIGAN RICHARD (Secretary, Treasurer, CFO) has filed a Form 3 on Genesis Biopharma, Inc |
| 03/22/2010 |
3
| Brooke Robert T. (President, CEO) has filed a Form 3 on Genesis Biopharma, Inc |
|
|